ACCESSION: MSBNK-SMB_Measured-HSA015P0482000
RECORD_TITLE: Characterized; LysoPE(18:0/0:0); LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'EL16_pos_10004': {'bp': 135182.0, 'sum': 383451.0}, 'EL01_pos_9988': {'bp': 117080.0, 'sum': 328745.0}, 'EL17_pos_10017': {'bp': 100123.0, 'sum': 310362.0}, 'EL14_pos_10017': {'bp': 85877.0, 'sum': 229424.0}, 'EL18_pos_9989': {'bp': 81882.0, 'sum': 242139.0}, 'EL02_pos_10083': {'bp': 80955.0, 'sum': 233116.0}, 'EL15_pos_10037': {'bp': 70822.0, 'sum': 211034.0}, 'EL06_pos_10037': {'bp': 70030.0, 'sum': 184701.0}, 'EL13_pos_10011': {'bp': 66264.0, 'sum': 191444.0}, 'EL19_pos_10084': {'bp': 55918.0, 'sum': 156345.0}, 'EL20_pos_10007': {'bp': 50435.0, 'sum': 159252.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 482.324380
COMMENT: PRECURSOR_M/Z_STDEV 0.000288
COMMENT: PRECURSOR_IN_MS1 mz 482.324279; int 59.051; delta(ppm) 0.755491
COMMENT: PROPOSED_CHARGE_STATE +1; mz 483.327652; int 14.076; cor 0.709
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.554; C30H43NO4; [M+H]+; delta(ppm) -4.554171
COMMENT: PROPOSED_MF SevenGoldenRules 2.406; C24H44N5O3P; [M+H]+; delta(ppm) -2.405899
COMMENT: PROPOSED_MF SevenGoldenRules 0.372; C23H48NO7P; [M+H]+; delta(ppm) 0.371896
COMMENT: PROPOSED_MF SevenGoldenRules 3.804; C25H43N3O6; [M+H]+; delta(ppm) 3.804146
COMMENT: PROPOSED_MF MS-FINDER 3.367; C23H48NO7P; [M+H]+; delta(ppm) 0.370447
COMMENT: PROPOSED_MF MS-FINDER 2.628; C30H43NO4; [M+H]+; delta(ppm) -4.545259
COMMENT: PROPOSED_MF MS-FINDER 2.541; C25H43N3O6; [M+H]+; delta(ppm) 3.795059
COMMENT: PROPOSED_MF MS-FINDER 2.293; C16H48N7O5PS; [M+H]+; delta(ppm) -1.051418
COMMENT: PROPOSED_MF MS-FINDER 2.141; C24H44N5O3P; [M+H]+; delta(ppm) -2.402400
COMMENT: PROPOSED_MF MS-FINDER 2.130; C18H43N9O4S; [M+H]+; delta(ppm) 2.373184
COMMENT: PROPOSED_MF MS-FINDER 2.062; C11H35N19O3; [M+H]+; delta(ppm) -0.019810
COMMENT: PROPOSED_MF MS-FINDER 2.039; C22H47N3O6S; [M+H]+; delta(ppm) -3.194283
COMMENT: PROPOSED_MF MS-FINDER 2.032; C19H39N13S; [M+H]+; delta(ppm) -0.399673
COMMENT: PROPOSED_MF MS-FINDER 2.006; C26H39N7O2; [M+H]+; delta(ppm) 1.022193
COMMENT: PROPOSED_MF MS-FINDER 1.976; C11H43N15O2S2; [M+H]+; delta(ppm) 0.951314
COMMENT: PROPOSED_MF MS-FINDER 1.923; C24H52NO2PS2; [M+H]+; delta(ppm) -1.431280
COMMENT: PROPOSED_MF MS-FINDER 1.857; C26H47N3OS2; [M+H]+; delta(ppm) 1.993320
COMMENT: PROPOSED_MF MS-FINDER 1.844; C15H47N9O4S2; [M+H]+; delta(ppm) -4.616138
COMMENT: PROPOSED_MF MS-FINDER 1.726; C18H51N5O3S3; [M+H]+; delta(ppm) 3.344313
COMMENT: PROPOSED_MF MS-FINDER 1.700; C12H44N13O3PS; [M+H]+; delta(ppm) 4.516074
COMMENT: PROPOSED_MF MS-FINDER 1.484; C18H59NO2S5; [M+H]+; delta(ppm) 4.315444
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1017.150; C23H48NO7P; [M+H]+; delta(ppm) 0.370447
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C23H48NO7P; [M+H]+; delta(ppm) 0.370447
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.735; C23H48NO7P; [M+H]+; delta(ppm) 0.370447
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C23H48NO7P; [M+H]+; delta(ppm) 0.370447
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; C23H48NO7P; Spectral Match to 1-Stearoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.886; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M+H]+; CCCCCCCCCCCCCCCCCC(=O)O[C@H](CO)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.806; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M+H]+; CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.581; LEBRETLBLINJDM-HSZRJFAPSA-N; [M+H]+; CCCCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[NH3+])OC(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.473; DIJCCOGBPIXGPC-UHFFFAOYSA-N; [M+H]+; O=C1NCCC(=O)NC(C(=O)OC(CCCCCCCC(C)CCC)C(C(=O)NC1=C)C)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.458; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M+H]+; CCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.505; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M+H]+; LysoPE(18:0/0:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.352; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M+H]+; LysoPE(0:0/18:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.130; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M+H]+; LysoPC(15:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.048; LEBRETLBLINJDM-HSZRJFAPSA-N; [M+H]+; 1-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine zwitterion
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.821; SKOJWJADWCAPSY-ZREVVVSZNA-N; [M+H]+; Stellettacholine B;(-)-Stellettacholine B
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.208; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M+H]+; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.968; WVBUWBFQFCAYTH-UHFFFAOYSA-N; [M+H]+; 4-(3-{6-[3-(2-azaniumylethyl)cyclopent-2-en-1-yl]-7-oxoheptyl}-4-(4-hydroxyphenyl)cyclohexylidene)butanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.963; YXXOGRSJPNKHOX-UHFFFAOYSA-N; [M+H]+; N-{2-[4-(2-methoxyphenyl)-2-(propan-2-yl)oxan-4-yl]ethyl}-N-{[4-(propan-2-yloxy)phenyl]methyl}propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.963; CNBKQMSUFXYEIC-UHFFFAOYSA-N; [M+H]+; 4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-6'-methoxy-1',8'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-4'-ene-4',7'-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.963; NTEKJBCOISZTPV-UHFFFAOYSA-N; [M+H]+; 4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-4'-methoxy-1',2'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-5'-ene-3',6'-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.959; BEYOUAZHQWMFJT-UHFFFAOYSA-N; [M+H]+; 7'-hydroxy-4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-6'-methoxy-1',8'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-4'-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.959; ZGCMGGKQYCJUHJ-UHFFFAOYSA-N; [M+H]+; 3'-hydroxy-4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-4'-methoxy-1',2'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-6'-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.955; GBZWEJDRTZPHRK-HUXSXENDSA-N; [M+H]+; (2S,6R,14R,15R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.876; XBUOPSRCSMOVAD-UHFFFAOYSA-N; [M+H]+; 5-[2-(3-acetamidopyrrolidin-1-yl)-2-oxoethyl]-6-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-decahydronaphthalen-2-yl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.875; DIJCCOGBPIXGPC-UHFFFAOYSA-N; [M+H]+; CNP0430365
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.875; JVIPHQOMYSTEIN-UHFFFAOYSA-N; [M+H]+; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.874; RYILBHSUHOGUJC-UHFFFAOYSA-N; [M+H]+; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.872; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M+H]+; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WVBUWBFQFCAYTH-UHFFFAOYSA-N; [M+H]+; 4-(3-{6-[3-(2-azaniumylethyl)cyclopent-2-en-1-yl]-7-oxoheptyl}-4-(4-hydroxyphenyl)cyclohexylidene)butanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M+H]+; LysoPE(18:0/0:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M+H]+; LysoPE(0:0/18:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LEBRETLBLINJDM-HSZRJFAPSA-N; [M+H]+; 1-hexadecyl-2-acetyl-sn-glycero-3-phosphoethanolamine zwitterion
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DIJCCOGBPIXGPC-UHFFFAOYSA-N; [M+H]+; CNP0430365
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.846; JVIPHQOMYSTEIN-UHFFFAOYSA-N; [M+H]+; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-4-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.846; RYILBHSUHOGUJC-UHFFFAOYSA-N; [M+H]+; 4-({[1-(2-{[(tert-butoxy)carbonyl]amino}-3-methylpentanoyl)piperidin-4-yl]formamido}methyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.735; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M+H]+; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.735; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M+H]+; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.598; BEYOUAZHQWMFJT-UHFFFAOYSA-N; [M+H]+; 7'-hydroxy-4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-6'-methoxy-1',8'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-4'-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.598; CNBKQMSUFXYEIC-UHFFFAOYSA-N; [M+H]+; 4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-6'-methoxy-1',8'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-4'-ene-4',7'-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.598; NTEKJBCOISZTPV-UHFFFAOYSA-N; [M+H]+; 4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-4'-methoxy-1',2'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-5'-ene-3',6'-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.598; ZGCMGGKQYCJUHJ-UHFFFAOYSA-N; [M+H]+; 3'-hydroxy-4-({3-[(2-hydroxypropyl)amino]phenyl}methyl)-4'-methoxy-1',2'-dimethylspiro[cyclopentane-1,13'-tetracyclo[6.5.0.0?,??.0?,?]tridecan]-6'-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.443; GBZWEJDRTZPHRK-HUXSXENDSA-N; [M+H]+; (2S,6R,14R,15R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.317; YXXOGRSJPNKHOX-UHFFFAOYSA-N; [M+H]+; N-{2-[4-(2-methoxyphenyl)-2-(propan-2-yl)oxan-4-yl]ethyl}-N-{[4-(propan-2-yloxy)phenyl]methyl}propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.033; RJZVWDTYEWCUAR-JOCHJYFZSA-N; [M+H]+; LysoPC(15:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; XBUOPSRCSMOVAD-UHFFFAOYSA-N; [M+H]+; 5-[2-(3-acetamidopyrrolidin-1-yl)-2-oxoethyl]-6-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-decahydronaphthalen-2-yl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; XEFNBUBDJCJOGM-OUJCMCIWSA-N; [M+H]+; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; BBYWOYAFBUOUFP-JOCHJYFZSA-N; [M+H]+; [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.703; GBZWEJDRTZPHRK-WVBWOLGJSA-N; [M+H]+; (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxy-5-methylhexan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.500; TWUKPJNGRBWVGE-VQWWACLZSA-N; [M+H]+; (2S)-2-[(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-11,15-dimethoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-16-yl]-3,3-dimethylbutan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.387; SHBAKEKBTCPUFI-OUJCMCIWSA-N; [M+H]+; [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hexadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.509; KIHAGWUUUHJRMS-JOCHJYFZSA-N; [M+H]+; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadecanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; HVSNCBOIQJFYLB-WMEGDYLPSA-N; [M+H]+; (2R)-2-[(2S,6R,14R,15S,16R)-11-butoxy-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,18-tetraen-16-yl]hexan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; LEBRETLBLINJDM-HSZRJFAPSA-N; [M+H]+; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.500; LHJYPOXVVYJDHU-UHFFFAOYSA-N; [M+H]+; 2-[2-(2-butoxy-3-methoxyphenyl)ethyl-[2-(propylcarbamoyloxy)ethyl]amino]ethyl N-propylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.283; GWPSWVKRTQYSAW-JOCHJYFZSA-N; [M+H]+; [(2R)-2,3-dihydroxypropyl] 2-(octadecanoylamino)ethyl hydrogen phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -9.757; BBYWOYAFBUOUFP; [M+H]+; 1-stearoyl-phosphatidylethenolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -35.988; KIHAGWUUUHJRMS; [M+H]+; Lysophosphatidylethanolamine(0:0/18:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -39.798; LEFGRTKRNXPBLH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -43.749; RJZVWDTYEWCUAR; [M+H]+; Lysophosphatidylcholine(15:0/0:0)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -68.115; YSZRVLWZLLULHT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.645; LEBRETLBLINJDM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.958; SKOJWJADWCAPSY; [M+H]+; [3-(2,12-dimethyltridecanoyloxy)-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.462; GWPSWVKRTQYSAW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.301; BBYWOYAFBUOUFP; [M+H]+; 1-stearoyl-phosphatidylethenolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.850; BBYWOYAFBUOUFP; [M+H]+; 1-Stearoyl-Sn-Glycero-3-Phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.733; RJZVWDTYEWCUAR; [M+H]+; 1-Pentadecanoyl-sn-glycero-3-phosphocholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.821; DTCAUIJNNGBAMH; [M+H]+; [(2R)-2-methoxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.220; KIHAGWUUUHJRMS; [M+H]+; 2-Octadecanoyl-Sn-Glycero-3-Phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.422; LEFGRTKRNXPBLH; [M+H]+; [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-methoxypropan-2-yl] heptadecanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -191.927; YSZRVLWZLLULHT; [M+H]+; 2-[hydroxy-[(2R)-3-methoxy-2-tetradecanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -219.015; LEBRETLBLINJDM; [M+H]+; 2-(Acetyloxy)-3-(hexadecyloxy)propyl 2-aminoethyl hydrogen phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -222.061; NDLORRZUDRJBPC; [M+H]+; [(2R)-3-heptanoyloxy-2-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -276.665; GWPSWVKRTQYSAW; [M+H]+; N-octadecanoyl-sn-glycero-3-phosphoethanolamine(1-)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -307.774; YYSFNFUXDNVHFT; [M+H]+; 1-(2-methoxy-6Z-heptadecenyl)-sn-glycero-3-phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.722; BBYWOYAFBUOUFP; [M+H]+; 1-Stearoyl-Sn-Glycero-3-Phosphoethanolamine
COMMENT: CONFIDENCE Level 3: Tentative candidate, LysoPE(18:0/0:0), BBYWOYAFBUOUFP-JOCHJYFZSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0011130;
CH$NAME: LysoPE(18:0/0:0)
CH$NAME: [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] octadecanoate
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C23H48NO7P
CH$EXACT_MASS: 481.316840
CH$SMILES: CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)O
CH$IUPAC: InChI=1S/C23H48NO7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(26)29-20-22(25)21-31-32(27,28)30-19-18-24/h22,25H,2-21,24H2,1H3,(H,27,28)/t22-/m1/s1
CH$LINK: CHEBI CHEBI:75036
CH$LINK: HMDB HMDB0011130
CH$LINK: INCHIKEY BBYWOYAFBUOUFP-JOCHJYFZSA-N
CH$LINK: LIPIDMAPS LMGP02050001
CH$LINK: PUBCHEM CID:9547068
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.305
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 482.324293
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-7009000000-b272d6af0d15bb1462f1
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  57.0337347 31.5004 57.034451 1.3676 8.25 -0.0333 10 f{C3H5O1}/4.27ppm,p-C20H44N1O6P1
  57.0701526 225.3337 57.070869 0.4906 20.75 0.6000 11 f{C4H9}/4.83ppm,p-C19H40N1O7P1
  62.0602623 237.7489 62.060995 0.4995 9.86 0.7000 10 f{C2H8N1O1}/3.58ppm,p-C21H41O6P1
  67.0543445 49.3777 67.055086 0.8948 11.72 0.1000 10 f{C5H7}/1.76ppm,p-C18H42N1O7P1
  71.0856459 135.3795 71.086389 0.9285 22.28 0.8182 11 f{C5H11}/1.68ppm,p-C18H38N1O7P1
  81.0699509 67.2103 81.070677 1.0238 15.57 0.6727 11 f{C6H9}/0.92ppm,p-C17H40N1O7P1
  83.0856151 41.9731 83.086335 1.0953 10.67 0.2606 11 f{C6H11}/1.06ppm,p-C17H38N1O7P1
  85.1012300 75.5800 85.101941 0.8931 11.75 0.7667 9 f{C6H13}/0.62ppm,p-C17H36N1O7P1
  95.0854506 86.0143 95.086103 0.8413 15.03 1.0000 10 f{C7H11}/-0.80ppm,p-C16H38N1O7P1
  98.9841695 56.7784 98.984791 1.3234 10.92 0.8545 11 f{H4O4P1}/-0.01ppm,p-C23H45N1O3
  155.0103799 56.9781 155.010694 1.3677 9.33 0.6000 9 f{C3H8O5P1}/-0.03ppm,p-C20H41N1O2
  341.3049181 999.0000 341.305353 0.5567 0.00 0.6970 11 f{C21H41O3}/-0.30ppm,p-C2H8N1O4P1
  342.3083909 198.9445 342.308826 1.4285 25.12 0.6333 10 ?
  421.2702934 68.0925 421.270756 1.4290 11.91 0.7143 8 f{C21H42O6P1}/-2.51ppm,p-C2H7N1O1
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  57.033735 31.50 31
  57.070153 225.33 225
  62.060262 237.75 237
  67.054344 49.38 49
  71.085646 135.38 135
  81.069951 67.21 67
  83.085615 41.97 41
  85.101230 75.58 75
  95.085451 86.01 86
  98.984170 56.78 56
  155.010380 56.98 56
  341.304918 999.00 999
  342.308391 198.94 198
  421.270293 68.09 68
//
